Patents by Inventor Jeffrey Axten

Jeffrey Axten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZAINDOLE INHIBITORS OF AURORA KINASES
    Publication number: 20080081808
    Abstract: The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.
    Type: Application
    Filed: September 14, 2007
    Publication date: April 3, 2008
    Inventors: Martha Sarpong, Nicholas Adams, Jeffrey Axten, Amita Chaudhari, Dashyant Dhanak, Toshihiro Hamajima, Kenneth Newlander, Cynthia Parrish, Jerry Adams, Domingos Silva, Jun Tang
  • Antibacterial Agents
    Publication number: 20070203127
    Abstract: Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
    Type: Application
    Filed: July 13, 2005
    Publication date: August 30, 2007
    Applicant: GLAXO GROUP LIMITED
    Inventors: William Miller, Jeffrey Axten, Mark Seefeld
  • Antibacterial agents
    Publication number: 20070004710
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: November 4, 2003
    Publication date: January 4, 2007
    Inventors: Jeffrey Axten, Timothy Gallagher, William Miller, Mark Seefeld
  • Compounds
    Publication number: 20060189604
    Abstract: Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
    Type: Application
    Filed: June 25, 2003
    Publication date: August 24, 2006
    Inventors: Jeffrey Axten, Robert Daines, David Davies, Timothy Gallagher, Graham Jones, William Miller, Neil Pearson, Israil Pendrak
  • Antibacterial agents
    Publication number: 20060166977
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: November 4, 2003
    Publication date: July 27, 2006
    Inventors: Jeffrey Axten, William Miller
  • Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
    Publication number: 20060116512
    Abstract: Quinoline and naphthridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: December 3, 2003
    Publication date: June 1, 2006
    Inventors: Jeffrey Axten, Catherine Dartois, Guy Marguerite Nadler, Neil Pearson
  • Compounds
    Publication number: 20060058287
    Abstract: Piperidine derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly in man.
    Type: Application
    Filed: June 25, 2003
    Publication date: March 16, 2006
    Inventors: Jeffrey Axten, Robert Daines, David Davies, Timothy Gallagher, Graham Jones, William Miller, Neil Pearson, Israil Pendrak
  • Antibacterial agents
    Publication number: 20060041123
    Abstract: Quinoline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans.
    Type: Application
    Filed: December 17, 2003
    Publication date: February 23, 2006
    Inventors: Jeffrey Axten, Gerald Brooks, Pamela Brown, David Davies, Timothy Gallagher, Roger Markwell, William Miller, Neil Pearson, Mark Seefeld
  • Imidazolium cxcr3 inhibitors
    Publication number: 20050272936
    Abstract: Imidazolium compounds of formula I compound of formula (I) wherein: A? is an anion; R1, R2 and R3 are the same or different and are hydrogen, C1-C6 alkyl, aryl, fused aryl, or heteroaryl; or are substituted aryl, fused aryl or heteroaryl; X and Y are the same or different and are —CH2, —C?O, —CHOH, —C?S, or —C?NR6; R4 and R5 are the same or different and are aryl, substituted aryl, heteroaryl, or substituted heteroaryl; and R6 is aryl, C1-C6 alkyl, OH, C1-C6 alkoxy, or aryloxy. are useful as inhibitors of a chemokine receptor knows as CXCR3 and its equivalent chemokine receptors.
    Type: Application
    Filed: May 29, 2003
    Publication date: December 8, 2005
    Inventors: Jeffrey Axten, James Foley, William Kingsbury, Henry Sarau